Wantai Bio TB detection kit added to UN procurement

Beijing Wantai Biological Pharmacy Enterprise (SSE:603392) announced that its self-developed tuberculosis infection T cell detection kit (TB-IGRA) has been included in the procurement list of the StopTB Partnership, managed by UNOPS. This inclusion signifies international recognition of Wantai Bio's diagnostic technology and provides access to UN and global multilateral procurement projects, especially in developing countries. This is expected to positively impact the company's international market expansion and product competitiveness. The TB-IGRA test kit aims to improve TB diagnosis and control efforts, particularly in resource-limited regions. While this represents a significant achievement, the company acknowledges potential risks related to international political dynamics, market conditions, regulatory changes, and exchange rate fluctuations that could affect overseas sales.